• Idoxuridine: Mechanism and Evidence Limits

  2026-10-07

  Idoxuridine, also called 5-iodo-2'-deoxyuridine, is a nucleoside analog associated with disruption of viral DNA synthesis. Its strongest research value is mechanistic interpretation in herpes simplex virus research, while vendor data and unrelated human-neuron findings should not be treated as clinical efficacy evidence.

• How NS1–DNMT1 Rewires HBoV1 Replication

  2026-10-07

  A 2024 PLOS Pathogens study identifies DNMT1-dependent methylation as a regulatory switch that supports human bocavirus 1 DNA replication while restraining viral RNA processing. It further shows that the viral NS1 protein promotes DNMT1 degradation through the ubiquitin–proteasome pathway, linking genome replication, RNA maturation, and viral protein expression.

• hUC-MSCs Restore Senescent Microglial Function

  2026-10-06

  A 2025 Aging Cell study reports that human umbilical cord-derived mesenchymal stem cells can lessen age-related cognitive decline by improving the function of senescent, lipid droplet-accumulating microglia. The proposed mechanism involves suppression of the NF-κB–SREBP1 pathway, with downstream effects on microglial lipid storage, phagocytosis, neuronal damage, and clearance of senescent neurons.

• Developmental SSRI Exposure and Motivation Deficits

  2026-10-06

  A 2026 Columbia University dissertation reports that developmental SSRI exposure selectively disrupts effortful reward seeking in adolescent and adult mice, while reward liking and Pavlovian learning remain comparatively preserved. Pharmacological antagonism or nucleus accumbens mu-opioid receptor knockdown improved the motivational phenotype, whereas additional SSRI treatment did not, identifying opioid-reward circuitry as a distinct mechanistic target.

• Adefovir Dipivoxil in Chronic HBV: Evidence Review

  2026-10-05

  The reference paper presents a clinically focused review of adefovir dipivoxil, linking its nucleotide-analog mechanism with evidence in HBeAg-positive and HBeAg-negative chronic hepatitis B. Its main contribution is an integrated assessment of antiviral activity, activity against lamivudine-resistant HBV, long-term tolerability, pharmacology, and resistance, while also identifying the limits of the available evidence.

• CXCR4–EGFR Heteromers Rewire Cancer Signaling

  2026-10-05

  Comez et al. provide complementary NanoBRET and nanobody-based proximity ligation evidence that CXCR4 and EGFR form signaling-competent oligomeric complexes. The study further shows ligand-dependent conformational and Gi-coupling changes, including detection of receptor proximity at endogenous levels in HeLa cells.

• DNA Frameworks Improve Enzymatic Oligonucleotide Synthesis

  2026-10-04

  Li and colleagues report a tetrahedral DNA nanostructure interface that improves primer presentation for enzymatic oligonucleotide synthesis. The study links ordered primer orientation and spacing with higher apparent enzyme accessibility, reduced deletion errors, and a reported 96.82% stepwise yield in a 60-nucleotide DNA information-storage demonstration, while leaving important questions about generality and independent validation.

• BCA Protein Quantification Kit K4102 Overview

  2026-10-03

  A supplier-described overview of APExBIO’s BCA Protein Quantification Kit, including its identity, conceptual assay scope, and evidence limitations.

• Natural Product Screening Identifies SARS-CoV-2 NSP15 Leads

  2026-10-02

  The 2021 reference study used structure-based virtual screening and molecular dynamics to identify thymopentin and oleuropein as predicted SARS-CoV-2 NSP15 binders. Its main contribution is a computational prioritization workflow for experimental testing, rather than proof of antiviral efficacy, making the findings useful for hypothesis generation and drug-repurposing research.

• VX-745 in Reliable Cell Assays

  2026-10-01

  This scenario-based guide explains how VX-745, SKU A8686, can help researchers interpret cell viability, proliferation, and inflammatory readouts through selective p38α MAPK inhibition. It covers assay design, compound handling, data interpretation, and practical supplier selection without conflating biochemical potency with cellular efficacy.

• Lanabecestat: Designing Safer BACE1 Assays

  2026-10-01

  Lanabecestat (AZD3293) enables a rigorous framework for studying BACE1 inhibition, amyloid-beta secretion, and neuronal function. This article translates key findings from a paired secretion-electrophysiology study into practical assay and interpretation strategies for Alzheimer's disease research.

• FLAG tag Peptide (DYKDDDDK): Uses & Limits

  2026-09-30

  The FLAG tag Peptide and DYKDDDDK peptide provide a compact epitope-tagging reagent for recombinant protein detection and affinity purification. Its enterokinase recognition sequence supports gentle elution from anti-FLAG M1 and M2 resins, but the peptide is not recommended for eluting 3X FLAG fusion proteins.

• AM251: Selective CB1 Receptor Antagonist

  2026-09-30

  AM251 is a potent CB1 receptor antagonist with reported nanomolar activity and applications in cannabinoid receptor research, neuroscience research, metabolism, and cell biology. Product-dossier evidence supports receptor antagonism, altered neurotransmitter release, anorectic effects in rats, and context-dependent cellular effects.

• EdU Flow Cytometry Assay Kits (Cy5) Workflow

  2026-09-29

  EdU Flow Cytometry Assay Kits (Cy5) provide a non-denaturing route to quantify S-phase DNA synthesis while preserving compatibility with cell-cycle dyes and antibody panels. This guide translates recent diabetic foot-ulcer biomarker findings into practical proliferation, genotoxicity, and pharmacodynamic workflows with controls and troubleshooting strategies.

• BCA Protein Quantification Kit K4102

  2026-09-29

  The Bicinchoninic Acid Assay (BCA) Protein Quantification Kit K4102 measures low-concentration total protein in dilute biochemical samples, including cell lysates and many detergent-containing preparations. It is intended for scientific research and sample-normalization workflows, not diagnostic, clinical, or medical testing.

8595 records 1/573 page Next 12345 下5页 Last page